Gujarat Kidney & Super Speciality Ltd IPO
Category
Healthcare
Sub Category
Multispeciality Hospitals
Listing
Mainboard | NSE • BSE
IPO Type
Bookbuilding IPO
Website
Visit CompanyIssue Price
₹108 – ₹114
Issue Size
₹250.8 Cr
Lot Size
128 shares
GMP
₹3.5
Listing Date
30 Dec 2025
Subscription: Retail 19.04x | NII 5.73x | QIB 1.06x
Total Subscription: 5.21x | Applications: 2,59,831
Status: LIVE (Closed for bids) | Last Updated: 24 Dec 2025
Key Signal:
Exceptional retail demand, healthy NII participation, and marginal institutional subscription ahead of listing.
IPO Timeline & Details
Open Date
20 Dec 2025
10:00 AM
Close Date
24 Dec 2025
3:30 PM
Allotment Date
27 Dec 2025
After market hours
Listing Date
30 Dec 2025
NSE • BSE
About the Company
Gujarat Kidney & Super Speciality Limited is a leading multispeciality healthcare provider in Gujarat with a focus on nephrology, dialysis, and specialized surgical services. The company operates multiple centers across the state and is expanding its footprint in advanced diagnostics and interventional procedures.
Know More →Why IPO?
- •Expand hospital network across 5 new cities in Gujarat and neighboring states
- •Modernize medical equipment and upgrade diagnostic centers
- •Strengthen balance sheet and reduce debt burden
- •Capitalize on growing demand for specialized healthcare in India
GMP & Market Sentiment
Current GMP
₹3.5
+3.24% from issue price
Expected Listing Price
₹117 – ₹123
Based on GMP
Market Sentiment
Bullish
Strong retail demand, stable GMP
Subscription Analysis
| Category | Subscription Times | Applications | Amount Applied (₹ Cr) |
|---|---|---|---|
| Retail | 19.04x | 1,95,412 | ₹225.8 |
| NII | 5.73x | 48,921 | ₹56.2 |
| QIB | 1.06x | 14,498 | ₹12.3 |
Insights:
- • Retail demand is exceptional at 19.04x, indicating strong investor confidence
- • NII participation (5.73x) shows healthy institutional interest
- • QIB subscription (1.06x) suggests conservative institutional buying strategy
Lot(s) Size Distribution For Gujarat Kidney & Super Speciality Limited
| Category | Min Lots (Shares) | Min Amount (₹) | Max Lots (Shares) | Max Amount (₹) |
|---|---|---|---|---|
| Retail | 1 (128) | ₹14,592 | 68 (8,704) | ₹9,92,256 |
| S-HNI | 1 (128) | ₹14,592 | 269 (34,432) | ₹39,28,448 |
| B-HNI | 270 (34,560) | ₹39,42,720 | 270 (34,560) | ₹39,42,720 |
IPO Reservation
| Category | Reservation % | Shares Allotted | Amount (₹ Cr) |
|---|---|---|---|
| Retail Investors | 35% | 21,95,000 | ₹250.8 Cr |
| NII (Non-Institutional Investors) | 15% | 9,40,000 | ₹107.5 Cr |
| QIB (Qualified Institutional Buyers) | 50% | 26,85,000 | ₹306.8 Cr |
KPI & Peer Comparison
| Metric | FY26E | FY25E | 3-Yr CAGR |
|---|---|---|---|
| Revenue (₹ Cr) | 425.5 | 380.2 | 12.1% |
| EBITDA (₹ Cr) | 78.5 | 68.4 | 14.8% |
| Net Profit (₹ Cr) | 45.3 | 38.9 | 18.2% |
| EPS (₹) | ₹5.65 | ₹4.86 | 16.3% |
Company Announcements
IPO subscription closes today at 3:30 PM
IPO subscription opens - strong retail demand expected
Price band announced: ₹108 - ₹114
Latest News
24 Dec 2025
Gujarat Kidney IPO closes with exceptional retail demand
Business Today
22 Dec 2025
Healthcare sector IPOs gain momentum in 2025
Mint
18 Dec 2025
Gujarat Kidney expands network to 5 new cities
Economic Times
Frequently Asked Questions
What is the minimum investment required for retail investors?
Retail investors can invest from ₹14,592 (1 lot of 128 shares at upper price band). Maximum is capped at ₹9,92,256 (68 lots).
When will the IPO allotment happen?
Allotment will take place on 27 Dec 2025 after market hours. Investors can check allotment status on the registrar's website.
Is there any lock-in period for shares?
No lock-in period for retail/NII shares. Promoter shares have a 18-month lock-in from listing date.
What is the expected listing date?
The IPO is expected to list on 30 Dec 2025 on both NSE and BSE.
How can I apply for the IPO?
You can apply online through your brokerage platform or bank. UPI mandate is required for payment.
Disclaimer:
This information is for educational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making investment decisions. IPO data sourced from BSE, NSE, and official company filings. GMP figures are indicative and subject to market conditions.